US Patent 11266661 Vaginal inserted estradiol pharmaceutical compositions and methods
Patent 11266661 was granted and assigned to TherapeuticsMD on March, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+235 characters)
Article
Patent abstract
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Brian Bernick0
Julia M. Amadio0
Sebastian Mirkin0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Apr, 2023
Golden AI
Infobox
Golden AI
Infobox
Patent Citations
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Mar, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 11266661 Vaginal inserted estradiol pharmaceutical compositions and methods
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11266661
Date of patent
March 8, 2022
Patent application number
15781840
Date Filed
December 7, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 11266661 Vaginal inserted estradiol pharmaceutical compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.